Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how RTO scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
RTO is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
RTO is good value based on its earnings relative to its share price (0.29x), compared to the US market average (27.98x)
What is the 52 week high and low for Rentokil Initial (NYSE: RTO)?
(NYSE: RTO) Rentokil Initial's 52-week high was $34.07, and its 52-week low was $19.60. It is currently -32.26% from its 52-week high and 17.76% from its 52-week low.
How much is Rentokil Initial stock worth today?
(NYSE: RTO) Rentokil Initial currently has 2,524,539,885 outstanding shares. With Rentokil Initial stock trading at $23.08 per share, the total value of Rentokil Initial stock (market capitalization) is $11.65B.
Rentokil Initial stock was originally listed at a price of $26.95 in Oct 12, 2022. If you had invested in Rentokil Initial stock at $26.95, your return over the last 2 years would have been -14.36%, for an annualized return of -7.46% (not including any dividends or dividend reinvestments).
How much is Rentokil Initial's stock price per share?
(NYSE: RTO) Rentokil Initial stock price per share is $23.08 today (as of Apr 17, 2025).
What is Rentokil Initial's Market Cap?
(NYSE: RTO) Rentokil Initial's market cap is $11.65B, as of Apr 21, 2025.
Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.
Rentokil Initial's market cap is calculated by multiplying RTO's current stock price of $23.08 by RTO's total outstanding shares of 2,524,539,885.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.